ATE396984T1 - Gewinnung von delta-9 tetrahydrocannabinol - Google Patents

Gewinnung von delta-9 tetrahydrocannabinol

Info

Publication number
ATE396984T1
ATE396984T1 AT03702721T AT03702721T ATE396984T1 AT E396984 T1 ATE396984 T1 AT E396984T1 AT 03702721 T AT03702721 T AT 03702721T AT 03702721 T AT03702721 T AT 03702721T AT E396984 T1 ATE396984 T1 AT E396984T1
Authority
AT
Austria
Prior art keywords
acid
tetrahydrocannabinol
thc
converted
extracted
Prior art date
Application number
AT03702721T
Other languages
English (en)
Inventor
Neil John Goodwin
Nicolas James Archer
Christopher Murray
Alan Kenneth Greenwood
Derek Mchattie
Original Assignee
Resolution Chemicals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0202396A external-priority patent/GB0202396D0/en
Application filed by Resolution Chemicals Ltd filed Critical Resolution Chemicals Ltd
Application granted granted Critical
Publication of ATE396984T1 publication Critical patent/ATE396984T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/348—Cannabaceae
    • A61K36/3482—Cannabis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]
    • Y10T436/255—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.] including use of a solid sorbent, semipermeable membrane, or liquid extraction

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Otolaryngology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Extraction Or Liquid Replacement (AREA)
  • Pyrane Compounds (AREA)
  • Optical Integrated Circuits (AREA)
  • Electric Double-Layer Capacitors Or The Like (AREA)
AT03702721T 2002-02-01 2003-02-03 Gewinnung von delta-9 tetrahydrocannabinol ATE396984T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0202396A GB0202396D0 (en) 2002-02-01 2002-02-01 Production of delta 9 tetrahydrocannabinol
GB0214022A GB0214022D0 (en) 2002-02-01 2002-06-18 Production of delta 9 tetrahydrocannabinol

Publications (1)

Publication Number Publication Date
ATE396984T1 true ATE396984T1 (de) 2008-06-15

Family

ID=27665366

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03702721T ATE396984T1 (de) 2002-02-01 2003-02-03 Gewinnung von delta-9 tetrahydrocannabinol

Country Status (17)

Country Link
US (3) US7524881B2 (de)
EP (2) EP1803717B1 (de)
JP (1) JP2005526715A (de)
CN (2) CN1642934A (de)
AT (1) ATE396984T1 (de)
AU (2) AU2003205844B2 (de)
BR (1) BR0307330A (de)
CA (1) CA2474951A1 (de)
DE (2) DE60332776D1 (de)
DK (1) DK1474412T3 (de)
ES (1) ES2305437T3 (de)
NO (1) NO20043209L (de)
NZ (2) NZ534430A (de)
PT (1) PT1474412E (de)
SI (1) SI1474412T1 (de)
WO (1) WO2003064407A2 (de)
ZA (1) ZA200405938B (de)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ534430A (en) * 2002-02-01 2007-09-28 Resolution Chemicals Ltd Production of delta 9 tetrahydrocannabinol from plant material
GB2391865B (en) * 2002-08-14 2005-06-01 Gw Pharma Ltd Improvements in the extraction of pharmaceutically active components from plant materials
KR101113162B1 (ko) * 2002-08-14 2012-06-20 지더블유 파마 리미티드 식물물질로부터 약제학적 활성성분의 추출의 개량
GB0222077D0 (en) 2002-09-23 2002-10-30 Gw Pharma Ltd Methods of preparing cannabinoids from plant material
GB2408978B (en) * 2002-09-23 2006-04-05 Gw Pharma Ltd Methods of preparing delta-9 tetrahydrocannabinol from plant material
TWI369203B (en) 2004-11-22 2012-08-01 Euro Celtique Sa Methods for purifying trans-(-)-△9-tetrahydrocannabinol and trans-(+)-△9-tetrahydrocannabinol
EP1827393A4 (de) * 2004-12-09 2012-04-18 Insys Therapeutics Inc Bei raumtemperatur stabile dronabinol-formulierungen
TWI366460B (en) 2005-06-16 2012-06-21 Euro Celtique Sa Cannabinoid active pharmaceutical ingredient for improved dosage forms
CA2623723A1 (en) * 2005-09-29 2007-04-12 Amr Technology, Inc. Process for production of delta-9-tetrahydrocannabinol
WO2008019146A2 (en) * 2006-08-04 2008-02-14 Insys Therapeutics Inc. Aqueous dronabinol formulations
US20080103193A1 (en) * 2006-10-26 2008-05-01 Trevor Percival Castor Methods for making compositions and compositions for treating pain and cachexia
GB0703284D0 (en) 2007-02-20 2007-03-28 Resolution Chemicals Ltd Delta 9 - tetrahydrocannabinol processing
JP2010535774A (ja) * 2007-08-06 2010-11-25 インシス セラピューティクス インコーポレイテッド 経口カンナビノイド液体製剤および治療方法
US20090042974A1 (en) * 2007-08-07 2009-02-12 Anson David Parker Compositions And Methods Relating To Extensible Transgenic Vector Assembler, Pestilence Ridder, Plus Cannabinoid Producer
GB0807915D0 (en) * 2008-05-01 2008-06-04 Resolution Chemicals Ltd Production of delta 9 tetrahydrocannabinol
US8343553B2 (en) 2011-04-18 2013-01-01 Hospodor Andrew D Essential element extractor
ES2806034T3 (es) * 2011-09-29 2021-02-16 Thc Pharm Gmbh The Health Concept Acidos carboxílicos de cannabinoide, sales de ácidos carboxílicos de cannabinoide, su preparación y aplicaciones
US9358259B2 (en) 2012-03-20 2016-06-07 Andrew David Hospodor Recycling cannabinoid extractor
WO2013165251A1 (en) * 2012-05-03 2013-11-07 Echo Pharmaceuticals B.V. Cannabis plant isolate comprising /\9-tetrahydrocannabinol and a method for preparing such an isolate
US20130337052A1 (en) * 2012-06-19 2013-12-19 Patricia Linert System and Method of Reducing Impairment of Alertness, Concentration, Motivation, and Creativity Caused by Medication
US9155767B2 (en) 2012-10-18 2015-10-13 Andrew D. Hospodor Essential element management
EP2968259B1 (de) * 2013-03-14 2022-09-14 SC Laboratories Inc. Bioaktive konzentrate und verwendungen davon
US9199960B2 (en) * 2013-05-02 2015-12-01 Frederick R. Ferri Method and apparatus for processing herbaceous plant materials including the cannabis plant
US9220294B2 (en) 2014-02-11 2015-12-29 Timothy McCullough Methods and devices using cannabis vapors
US9380813B2 (en) 2014-02-11 2016-07-05 Timothy McCullough Drug delivery system and method
US10821240B2 (en) 2014-02-11 2020-11-03 Vapor Cartridge Technology Llc Methods and drug delivery devices using cannabis
US20170312327A1 (en) * 2014-11-17 2017-11-02 Connoisseur Holdings, Llc Extraction devices, systems, and methods
US10207198B2 (en) * 2015-01-22 2019-02-19 Phytoplant Research S.L. Methods of purifying cannabinoids using liquid:liquid chromatography
US11034639B2 (en) 2015-01-22 2021-06-15 Phytoplant Research S.L. Methods of purifying cannabinoids using liquid:liquid chromatography
DK3247371T3 (da) * 2015-01-22 2020-06-15 Phytoplant Res S L Fremgangsmåder til oprensning af cannabinoider, sammensætninger og kits dertil
US11040295B2 (en) 2015-02-06 2021-06-22 Joseph Francis Payack Method and apparatus for extracting plant oils using ethanol water
WO2016179247A1 (en) 2015-05-07 2016-11-10 Axim Biotechnologies, Inc. Process to extract and purify delta-9-tetrahydrocannabinol
US10913071B2 (en) 2016-03-09 2021-02-09 Pearson Incorporated Scalper apparatus and processing system
US10499584B2 (en) 2016-05-27 2019-12-10 New West Genetics Industrial hemp Cannabis cultivars and seeds with stable cannabinoid profiles
WO2018000094A1 (en) 2016-06-29 2018-01-04 CannScience Innovations Inc. Decarboxylated cannabis resins, uses thereof and methods of making same
US10322487B1 (en) 2016-07-15 2019-06-18 Pearson Incorporated Roller mill grinding apparatus with regenerative capability
BR112019000816B1 (pt) * 2016-07-15 2021-07-20 S.S. Steiner, Inc. Descarboxilação de ácido canabidiólico em biomassa de cânhamo e extrato de cânhamo
US10239808B1 (en) 2016-12-07 2019-03-26 Canopy Holdings, LLC Cannabis extracts
US10702495B2 (en) 2017-02-20 2020-07-07 Nexien Biopharma, Inc. Method and compositions for treating dystrophies and myotonia
IT201700085508A1 (it) * 2017-07-26 2019-01-26 Inalco S R L Metodo per la produzione di cannabinoidi da varietà di canapa industriale
US10807098B1 (en) 2017-07-26 2020-10-20 Pearson Incorporated Systems and methods for step grinding
US10272360B2 (en) 2017-08-05 2019-04-30 Priya Naturals, Inc. Phytochemical extraction system and methods to extract phytochemicals from plants including plants of the family Cannabaceae sensu stricto
US10406453B2 (en) * 2017-09-29 2019-09-10 NextLeaf Solutions Ltd. Cannabinoid extraction process using brine
US10941102B2 (en) * 2017-11-29 2021-03-09 Robert Henry Wohleb Aqueous leaching method to produce microcrystalline powder
EP3746419A1 (de) * 2018-01-29 2020-12-09 Phytoplant Research S.L. Verfahren zur reinigung von cannabinoiden unter verwendung von flüssig-flüssigchromatografie
CA3089994A1 (en) 2018-01-31 2019-08-08 Canopy Holdings, LLC Hemp powder
US11325133B1 (en) 2018-07-26 2022-05-10 Pearson Incorporated Systems and methods for monitoring the roll diameter and shock loads in a milling apparatus
WO2020060959A1 (en) * 2018-09-17 2020-03-26 Sorbent Technologies, Inc. Methods for removing contaminants from plant-derived pharmaceuticals
WO2020077153A1 (en) 2018-10-10 2020-04-16 Canopy Holdings, LLC Synthesis of cannabigerol
US10751722B1 (en) 2018-10-24 2020-08-25 Pearson Incorporated System for processing cannabis crop materials
US20220079880A1 (en) * 2019-01-17 2022-03-17 Thomas Piccariello Solid micellar compositions of cannabinoid acids
US10785906B2 (en) 2019-02-19 2020-09-29 Pearson Incorporated Plant processing system
AU2020247619A1 (en) * 2019-03-24 2021-11-11 Omega Life Science Ltd. Electronic cigarettes
US20200323791A1 (en) 2019-04-11 2020-10-15 Mantrose-Haueser Co., Inc. Cannabis delivery with protective glaze coating
WO2020219687A1 (en) 2019-04-23 2020-10-29 Joint Venture Holdings, LLC Cannabis processing systems and methods
EP3750528A1 (de) 2019-06-11 2020-12-16 Nexien Biopharma, Inc. Zusammensetzungen zur behandlung von dystrophien und myotonie
CA3154135A1 (en) 2019-09-16 2021-03-25 Vapor Cartridge Technology Llc Drug delivery system with stackable substrates
US10757860B1 (en) 2019-10-31 2020-09-01 Hemp Processing Solutions, LLC Stripper apparatus crop harvesting system
US10933424B1 (en) 2019-12-11 2021-03-02 Pearson Incorporated Grinding roll improvements
CN111039760A (zh) * 2019-12-16 2020-04-21 福建省中科生物股份有限公司 一种制备酚类化合物的方法
US11351476B2 (en) * 2020-01-07 2022-06-07 Agrify Corporation Method for chemical separation of cannabinoids
CN115605195A (zh) 2020-03-04 2023-01-13 普利欧制药有限公司（Us） 用于治疗大麻使用病症和缓解大麻素戒断的方法和组合物
CA3179204A1 (en) 2020-06-09 2021-12-16 David A. Fisher Process for isolation and purification of thca from cannabis
AR123432A1 (es) 2020-09-04 2022-11-30 Herbolea Biotech S R L Concentrado de cannabinoides libre de thc, método de obtención del mismo y su uso
US12029718B2 (en) 2021-11-09 2024-07-09 Cct Sciences, Llc Process for production of essentially pure delta-9-tetrahydrocannabinol
US11242328B1 (en) * 2021-02-25 2022-02-08 Acid Neutral Alkaline Laboratory Heterogeneous catalyst and method for preparation of aromatic tricyclic pyrans
US11352337B1 (en) * 2021-06-02 2022-06-07 Acid Neutral Alkaline Laboratory Zeolite catalyst and method for preparation of aromatic tricyclic pyrans
CN115260005B (zh) * 2022-08-30 2024-01-30 晨光生物科技集团股份有限公司 一种纯化提取大麻二酚的方法与应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5342971A (en) * 1992-12-29 1994-08-30 The Australian National University Process for the preparation of dibenzo[b,d]pyrans
WO1996034534A1 (en) * 1995-05-05 1996-11-07 Hauser Inc. High purity carnosic acid from rosemary and sage extracts by ph-controlled precipitation
GB9726916D0 (en) * 1997-12-19 1998-02-18 Danbiosyst Uk Nasal formulation
US6730519B2 (en) * 1998-10-26 2004-05-04 The University Of Mississippi Method of preparing delta-9-tetrahydrocannabinol
US6365416B1 (en) * 1998-10-26 2002-04-02 The University Of Mississippi Method of preparing delta-9-tetrahydrocannabinol
NZ534430A (en) * 2002-02-01 2007-09-28 Resolution Chemicals Ltd Production of delta 9 tetrahydrocannabinol from plant material

Also Published As

Publication number Publication date
DE60332776D1 (de) 2010-07-08
SI1474412T1 (sl) 2008-10-31
WO2003064407A3 (en) 2003-10-16
EP1803717A3 (de) 2007-07-11
EP1803717A2 (de) 2007-07-04
US20050049298A1 (en) 2005-03-03
AU2003205844B2 (en) 2006-10-12
CN1642934A (zh) 2005-07-20
US20050171361A1 (en) 2005-08-04
ES2305437T3 (es) 2008-11-01
CN100999513A (zh) 2007-07-18
EP1803717B1 (de) 2010-05-26
CA2474951A1 (en) 2003-08-07
US7592468B2 (en) 2009-09-22
DK1474412T3 (da) 2008-09-01
JP2005526715A (ja) 2005-09-08
NZ552547A (en) 2008-03-28
DE60321318D1 (de) 2008-07-10
NZ534430A (en) 2007-09-28
AU2006252300B2 (en) 2009-02-12
EP1474412B1 (de) 2008-05-28
WO2003064407A2 (en) 2003-08-07
EP1474412A2 (de) 2004-11-10
ZA200405938B (de) 2006-05-31
AU2006252300A1 (en) 2007-01-25
US7524881B2 (en) 2009-04-28
NO20043209L (no) 2004-10-28
US20090253783A1 (en) 2009-10-08
BR0307330A (pt) 2004-12-07
PT1474412E (pt) 2008-07-04

Similar Documents

Publication Publication Date Title
ATE396984T1 (de) Gewinnung von delta-9 tetrahydrocannabinol
EA200300211A1 (ru) Азабициклические соединения, способ их получения и их применение в качестве лекарственных средств, в частности в качестве антибактериальных средств
BR0312695A (pt) Derivados de 1h-pirrolidina-2,4-diona espirocìclicos substituìdos por cis-alcóxi
BRPI0318811B8 (pt) derivados de ciclohexanol espirocíclicos
EA200100451A1 (ru) Замещенные аналоги бензопирана для лечения воспаления
EP1434773A4 (de) Heteroarylsubstituierte tetrazolmodulatoren des metabotropischen glutamatrezeptors-5
PT1133283E (pt) Um metodo de producao de particulas de farmaco
NO20051038L (no) Nye effektorkonjugater, fremgangsmate for deres fremstilling, og deres farmasoytiske bruk
ATE252571T1 (de) Tocotrienole und geranylgeraniol aus nebenprodukten von bixa orellana
ATE420099T1 (de) Medikament zur wachstumsinhibierung von tumoren
EA200500223A1 (ru) Новые конъюгаты - эффекторы, способ их получения и их фармацевтическое применение
ATE272436T1 (de) Mikrofiltration unter verwendung von aktivkohle
BR0309357A (pt) Método para fabricar cristais de esteróides, cristais obtìveis de acordo com esse método, e formulações farmacêuticas
ATE406871T1 (de) Konzentrierte wässrige ambroxollösung
PT1135517E (pt) Producao de acido ascorbico usando levedura
ES2106591T3 (es) Procedimiento para la preparacion de n-cloroacetilglutamina.
DK1450786T3 (da) Isoflavonkoncentrater samt fremgangsmåde til fremstilling deraf
DE60133395D1 (de) Verfahren zur herstellung von alpha'-chlorketonen
ES2098370T3 (es) Derivado del acido epoxisuccinamico.
ITMI20022409A1 (it) Procedimento per la purificazione di 1, 4-butandiolo mononitrato.
SE9900118L (sv) Processor och metod för att exekvera instruktioner från flera instruktionskällor
EP1258478A4 (de) Verfahren zur herstellung von chinoloncarbonsäuren und ihre zwischenprodukte
BR9810031A (pt) Derivados de ácido pirrolidina carboxìlico como antagonistas á endotelina
BR0311409A (pt) Processo para produção de modificações cristalinas especìficas de substâncias polimorfas
SE9802939D0 (sv) New process

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1474412

Country of ref document: EP

REN Ceased due to non-payment of the annual fee